By analyzing lung adenocarcinoma (LUAD) survival data, we found that high OSBP and OSBPL2 expressions are associated with significantly longer patient survivals, suggesting that downregulation of these genes is a signature of tumor malignancy (Fig. 6, G and H). This evidence concerns the gene OSBPL2 and lung adenocarcinoma.